Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIG
1851
DELISTED
Big Lots, Inc.
BIG
| $13.1M | ﹤0.01% |
303,041
+5,224
| +2% | +$284K |
|
|
RVNC
1852
DELISTED
Revance Therapeutics, Inc.
RVNC
| $13.1M | ﹤0.01% |
471,267
+3,056
| +0.7% | +$87.2K |
|
1853
Alamo Group
ALG
$1.99B
| $13.1M | ﹤0.01% |
94,091
-1,315
| -1% | -$194K |
|
1854
Sana Biotechnology
SANA
$1.1B
| $13.1M | ﹤0.01% |
582,797
+355,387
| +156% | +$7.46M |
|
1855
Huazhu Hotels Group
HTHT
$12.5B
| $13.1M | ﹤0.01% |
285,790
+10,231
| +4% | +$483K |
|
1856
Tennant Co
TNC
$1.15B
| $13.1M | ﹤0.01% |
176,997
+6,910
| +4% | +$519K |
|
1857
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $13.1M | ﹤0.01% |
386,473
+3,525
| +0.9% | +$112K |
|
|
XM
1858
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $13M | ﹤0.01% |
304,750
+29,452
| +11% | +$1.25M |
|
1859
Opko Health
OPK
$1.04B
| $13M | ﹤0.01% |
3,550,759
-90,897
| -2% | -$338K |
|
1860
Griffon
GFF
$4.8B
| $12.9M | ﹤0.01% |
525,863
+32,616
| +7% | +$778K |
|
1861
First Interstate BancSystem
FIBK
$3.7B
| $12.9M | ﹤0.01% |
321,145
+10,210
| +3% | +$433K |
|
|
SPWR
1862
DELISTED
SunPower Corporation Common Stock
SPWR
| $12.9M | ﹤0.01% |
570,080
-17,755
| -3% | -$415K |
|
|
NBIS
1863
Nebius Group N.V.
NBIS
$69.3B
| $12.9M | ﹤0.01% |
162,143
+20,154
| +14% | +$1.47M |
|
|
AVNS
1864
DELISTED
Avanos Medical
AVNS
| $12.9M | ﹤0.01% |
414,085
+7,342
| +2% | +$249K |
|
|
ZUO
1865
DELISTED
Zuora, Inc.
ZUO
| $12.8M | ﹤0.01% |
774,581
+50,406
| +7% | +$849K |
|
1866
Joby Aviation
JOBY
$8.17B
| $12.8M | ﹤0.01% |
+1,276,127
| New | +$12.9M |
|
1867
Archrock
AROC
$5.85B
| $12.8M | ﹤0.01% |
1,549,190
+108,568
| +8% | +$873K |
|
1868
Westamerica Bancorp
WABC
$1.39B
| $12.7M | ﹤0.01% |
226,547
+6,860
| +3% | +$385K |
|
1869
GoodRx Holdings
GDRX
$1.27B
| $12.7M | ﹤0.01% |
310,219
+10,231
| +3% | +$371K |
|
1870
Usana Health Sciences
USNA
$252M
| $12.6M | ﹤0.01% |
137,059
+5,459
| +4% | +$525K |
|
1871
Microvision
MVIS
$89.7M
| $12.6M | ﹤0.01% |
76,218
+49,909
| +190% | +$10.4M |
|
1872
Delek US
DK
$4.18B
| $12.6M | ﹤0.01% |
701,039
+28,564
| +4% | +$487K |
|
1873
Lemonade
LMND
$4.1B
| $12.6M | ﹤0.01% |
187,407
+92,327
| +97% | +$7.44M |
|
1874
Columbus McKinnon
CMCO
$550M
| $12.6M | ﹤0.01% |
259,671
+7,653
| +3% | +$346K |
|
1875
Ameresco
AMRC
$1.47B
| $12.5M | ﹤0.01% |
214,611
+38,227
| +22% | +$2.52M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.